Business

PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) to Accept Term Sheet from Leading Wall Street Bank Behind Many Leading Crypto Strategies

NEWPORT BEACH, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- PMGC Capital LLC (“PMGC Capital”), a wholly owned subsidiary of PMGC Holdings Inc. (NASDAQ: ELAB), today issued a public statement urging Alaunos Therapeutics, Inc. (NASDAQ: TCRT) to accept and act upon the term sheet previously facilitated through a leading Wall Street Bank. As disclosed in PMGC Capital’s May 14, 2025 press release, available on the PMGC Holdings website, PMGC Capital holds a significant ownership position in Alaunos and

articlePmgc Holdings Inc.June 18, 20253/company/elevai-labs-inc-common-stock/news/pmgc-capital-llc-urges-alaunos-therapeutics-nasdaq-tcrt-to-accept-term-sheet-from-leading-wall-street-bank-behind-many-leading-crypto-strategies
PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) to Accept Term Sheet from Leading Wall Street Bank Behind Many Leading Crypto Strategies

About this update from Pmgc Holdings Inc.

[{"type":"image","alt":"PMGC Holdings Inc.","displaySize":"","headline":null,"caption":"PMGC Holdings Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":243,"url":"https://media.zenfs.com/en/globenewswire.com/546741842ddd656c130df2366fbdd9a7"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/FeIekmuAEqql.btYh_OPxw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTM0MDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/546741842ddd656c130df2366fbdd9a7","width":300,"height":243},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/FeIekmuAEqql.btYh_OPxw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTM0MDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/546741842ddd656c130df2366fbdd9a7","width":300,"height":243}},"lazy":false},{"type":"text","content":"NEWPORT BEACH, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- PMGC Capital LLC (“PMGC Capital”), a wholly owned subsidiary of PMGC Holdings Inc. (NASDAQ: ELAB), today issued a public statement urging Alaunos Therapeutics, Inc. (NASDAQ: TCRT) to accept and act upon the term sheet previously facilitated through a leading Wall Street Bank.","length":333,"tagName":"p"},{"type":"text","content":"As disclosed in PMGC Capital’s May 14, 2025 press release, available on the PMGC Holdings website, PMGC Capital holds a significant ownership position in Alaunos and continues to act in the best interest of all shareholders.","length":224,"tagName":"p"},{"type":"text","content":"The proposed financing sent to the board on 5/25/2025, introduced by PMGC Capital and led by a leading wall street bank, represents a compelling, value-aligned opportunity for Alaunos. The bank recently behind many Leading Treasury Strategy transactions that has since garnered widespread institutional attention and market momentum.","length":333,"tagName":"p"},{"type":"text","content":"“We believe this term sheet offers Alaunos a timely and strategic path forward,” said Braeden Lichti, “This is one of the cleanest financing offers we've seen for a micro-cap company,” said Braeden Lichti, CEO of Northstrive Companies Inc., Manager of PMGC Capital, “It’s non-toxic, well-structured, and provides the company with substantial capital while potentially creating massive value for shareholders. The board should not miss this opportunity.”","length":457,"tagName":"p"},{"type":"text","content":"PMGC Capital remains committed to work...

More updates from Pmgc Holdings Inc.

PMGC Holdings Inc.PMGC CapitalWall Street BankAlaunos Therapeutics, Inc.PMGC Holdings IncBraeden Lichti